Immunohistochemistry Digital Breast Cancer Panel 4 Test
Comprehensive Breast Cancer Biomarker Analysis
The Immunohistochemistry Digital Breast Cancer Panel 4 Test represents a cutting-edge approach to breast cancer diagnosis and treatment planning. This advanced digital pathology test utilizes immunohistochemistry (IHC) technology to analyze four crucial biomarkers that determine tumor behavior and guide personalized treatment strategies. By providing detailed information about estrogen receptors (ER), progesterone receptors (PR), HER-2 status, and Ki67 proliferation index, this comprehensive panel helps oncologists make informed decisions about targeted therapies and predict treatment response.
What This Test Measures and Detects
Our comprehensive breast cancer panel evaluates four essential biomarkers that significantly impact treatment decisions and prognosis:
- Estrogen Receptor (ER): Determines if cancer cells have estrogen receptors, indicating potential response to hormone therapy
- Progesterone Receptor (PR): Assesses progesterone receptor status for additional hormone therapy guidance
- HER-2 Protein: Identifies HER-2 positive cancers that may respond to targeted therapies like Herceptin
- Ki67 Proliferation Index: Measures tumor cell growth rate to assess aggressiveness
- Pathologist Review: Includes expert evaluation for presence of malignant cells
- Photomicrograph Documentation: Provides visual documentation of tissue samples
Who Should Consider This Test
This comprehensive breast cancer panel is recommended for:
- Newly diagnosed breast cancer patients requiring biomarker analysis
- Patients with suspicious breast lumps or abnormal mammogram findings
- Individuals with family history of breast cancer undergoing diagnostic evaluation
- Patients needing treatment planning for hormone therapy or targeted treatments
- Those requiring recurrence monitoring or treatment response assessment
- Patients with metastatic breast cancer needing biomarker characterization
Key Benefits of the Breast Cancer Panel
- Personalized Treatment Planning: Guides selection of hormone therapies and targeted treatments
- Prognostic Information: Provides insights into cancer aggressiveness and likely progression
- Treatment Response Prediction: Helps predict how tumors may respond to specific therapies
- Comprehensive Biomarker Analysis: Single test evaluates multiple critical biomarkers
- Digital Pathology Accuracy: Advanced digital imaging ensures precise results
- Expert Pathologist Review: Includes specialized evaluation by experienced pathologists
Understanding Your Test Results
Your test results will provide detailed information about each biomarker:
- ER/PR Status: Positive results indicate potential response to hormone therapy
- HER-2 Status: Positive results suggest eligibility for HER-2 targeted therapies
- Ki67 Index: Higher percentages indicate more aggressive tumor growth
- Molecular Subtype Classification: Helps categorize breast cancer into specific subtypes
- Treatment Recommendations: Results guide specific therapy options
Your oncologist will discuss the results in detail and explain how they impact your treatment plan and prognosis.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry Digital Breast Cancer Panel 4 Test | $250 USD | $376 USD |
Nationwide Testing Availability
We have branches across the United States, making advanced breast cancer testing accessible to patients nationwide. Our facilities are located in major metropolitan areas including:
- New York City and surrounding areas
- Los Angeles and Southern California
- Chicago and Midwest regions
- Houston and Texas locations
- Miami and Florida centers
- And many other major cities
Take Control of Your Breast Cancer Journey
Don’t leave your treatment decisions to chance. The Immunohistochemistry Digital Breast Cancer Panel 4 Test provides the critical information needed to develop the most effective treatment strategy for your specific cancer type. With our discounted price of $250 USD (regularly $376), this comprehensive analysis is both accessible and essential for optimal care.
Ready to get started? Book your test today or call our dedicated healthcare team at +1(267) 388-9828 to schedule your appointment. Our specialists are available to answer your questions and guide you through the testing process.
